Biological Therapy Analysis & Statistics, June 2013 (p8)

Talk to Amrita

+1 718 303 2019

Search inside this page

All regions

You might be interested in: stem cell, cell therapy, tissue engineering, more »

211-240 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

California Stem Cell, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

California Stem Cell, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
  • Countries : United States
Cytokine PharmaSciences, Inc. (formerly Cytokine Networks, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cytokine PharmaSciences, Inc. (formerly Cytokine Networks, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
Stem Cell Sciences plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Stem Cell Sciences plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
California Stem Cell, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

California Stem Cell, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
  • Countries : United States
Mesenchymal Stem Cells, Advances & Applications

Mesenchymal Stem Cells, Advances & Applications

  • $ 3 495
  • Industry report
  • June 2013
  • by BioInformant Worldwide, L.L.C.

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and ...

  • Industries : Biological Therapy
Complete 2012-13  Induced Pluripotent Stem Cell Industry Report

Complete 2012-13 Induced Pluripotent Stem Cell Industry Report

  • $ 3 450
  • Industry report
  • June 2013
  • by BioInformant Worldwide, L.L.C.

EXECUTIVE SUMMARY Stem cell research and experimentation has been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their †...

  • Industries : Biological Therapy
  • Countries : United States
Global Gene Therapy Market Analysis

Global Gene Therapy Market Analysis

  • $ 1 200
  • Industry report
  • June 2013
  • by RNCOS

Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the ...

  • Industries : Biological Therapy
  • Countries : World
Cytokine PharmaSciences, Inc. - Product Pipeline Review - 2013

Cytokine PharmaSciences, Inc. - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • May 2013
  • by Global Markets Direct

Cytokine PharmaSciences, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?Cytokine PharmaSciences, Inc. - Product Pipeline Review - 2013? provides data on ...

  • Industries : Biological Therapy
  • Countries : World
Cell Therapy in the US - Industry Market Research Report

Cell Therapy in the US - Industry Market Research Report

  • $ 1 020
  • Industry report
  • May 2013
  • by Ibisworld

Cell Therapy The Cell Therapy industry is a fast-growing industry. The demand for the industry's products and services depends primarily on the level of investment in medical technology. Strong growth ...

  • Industries : Biological Therapy
  • Countries : United States
Eckert & Ziegler BEBIG S.A. (EZBG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Eckert & Ziegler BEBIG S.A. (EZBG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary Eckert & Ziegler BEBIG S.A. (Eckert & Ziegler) formerly International Brachytherapy S.A. is a Europe-based medical device company, it focuses on treatment of cancer using brachytherapy, a special ...

  • Industries : Biological Therapy
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: NeoStem, Inc. (NBS)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: NeoStem, Inc. (NBS)

  • $ 250
  • Company report
  • May 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
ES Cell International Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ES Cell International Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary ES Cell International Pte, Ltd. (ESI) is a regenerative medicine company, based in Singapore. The company develops human embryonic stem cell technologies for research and commercial applications. ...

  • Industries : Biological Therapy
  • Countries : Singapore
Histostem, Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Histostem, Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary Histostem, Co., Ltd. is a biotechnology company well known for its development of the technology of mixing cord blood for stemcell transplantation. The company is engaged in cell therapy research, ...

  • Industries : Biological Therapy
TiGenix NV (TIG) - Product Pipeline Analysis, 2013 Update

TiGenix NV (TIG) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary TiGenix NV (TiGenix) is a biomedical cell therapy company. The company specializes in the development of innovative local treatments for damaged and diseased tissues. It mainly focuses on the therapeutic ...

  • Industries : Biological Therapy
  • Countries : Spain
iPS cell Generation patent landscape - 2013/03

iPS cell Generation patent landscape - 2013/03

  • $ 6 860
  • Industry report
  • May 2013
  • by France Innovation Scientifique et Transfert

Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...

  • Industries : Biological Therapy
  • Countries : United States, South Korea, China
iPS cell Differentiation patent landscape - 2013/03

iPS cell Differentiation patent landscape - 2013/03

  • $ 4 060
  • Industry report
  • May 2013
  • by France Innovation Scientifique et Transfert

Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...

  • Industries : Biological Therapy
  • Countries : United States, South Korea, China
Chip-Man Technologies Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chip-Man Technologies Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2013
  • by Global Data

Summary Chip-Man Technologies Ltd. (Chip-Man) is a healthcare technology company, based in Finland. The company conducts research, develops, manufactures and commercializes medical products. It offers ...

  • Industries : Biological Therapy
  • Countries : Finland
Maxygen, Inc. (Symbol:MAXY) SWOT Analysis, Strategy, Revenues and Profits

Maxygen, Inc. (Symbol:MAXY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
SkinEthic Laboratories - Strategic SWOT Analysis Review

SkinEthic Laboratories - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • April 2013
  • by Global Data

SkinEthic Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed ...

  • Industries : Biological Therapy
Competitor Analysis: G-CSF and GM-CSF

Competitor Analysis: G-CSF and GM-CSF

  • $ 528
  • Industry report
  • April 2013
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products ...

  • Industries : Biological Therapy
  • Countries : Taiwan, South Korea, India, China
B-Cell Leukemia - Pipeline Review, H1 2013

B-Cell Leukemia - Pipeline Review, H1 2013

  • $ 2 000
  • Industry report
  • February 2013
  • by Global Markets Direct

B-Cell Leukemia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'B-Cell Leukemia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World
World Biological Therapy: Natural Killer Cell Lymphomas - Pipeline Review, H1 2012

World Biological Therapy: Natural Killer Cell Lymphomas - Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2013
  • by Global Markets Direct

This report provides information on the therapeutic development for Natural Killer Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Biological Therapy
  • Countries : United States, World
Vitro Diagnostics, Inc. (VODG) - Medical Equipment - Deals and Alliances Profile

Vitro Diagnostics, Inc. (VODG) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2013
  • by Global Data

Summary Vitro Diagnostics, Inc. (Vitro Diagnostics) is a biopharmaceutical company, that carries out the development and commercialization of adult stem cell technology which is used for stem cell research, ...

  • Industries : Biological Therapy
  • Countries : United States
Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2013
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company, based in Australia. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. ...

  • Industries : Biological Therapy
  • Countries : Australia
The 2013 Report on Cancer Therapy Pharmaceuticals: World Market Segmentation by City

The 2013 Report on Cancer Therapy Pharmaceuticals: World Market Segmentation by City

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important ...

  • Industries : Biological Therapy
  • Countries : World
Global Brachytherapy Devices Market 2012-2016

Global Brachytherapy Devices Market 2012-2016

  • $ 2 500
  • Industry report
  • January 2013
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Brachytherapy Devices market to grow at a CAGR of 2.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant ...

  • Industries : Biological Therapy
  • Countries : World
The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in Japan

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the latent demand outlook for cancer therapy pharmaceuticals across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Biological Therapy
  • Countries : Japan
The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in the United States

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the latent demand outlook for cancer therapy pharmaceuticals across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Biological Therapy
  • Countries : United States
The 2013-2018 World Outlook for Cancer Therapy Pharmaceuticals

The 2013-2018 World Outlook for Cancer Therapy Pharmaceuticals

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the world outlook for cancer therapy pharmaceuticals across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Biological Therapy
  • Countries : World
Fanconi Anemia - Pipeline Review, H2 2012

Fanconi Anemia - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • December 2012
  • by Global Markets Direct

Fanconi Anemia - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Fanconi Anemia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World
About 600 reports

Download Unlimited Documents from Trusted Public Sources

Avagenesis - Company Report, July 2014

  • Avagenesis Corp. (tsxv: Vva) - Unique Automated Bioprocessing an...
  • July 2014
    25 pages
  • Stem Cell  

    Cell Therapy  

  • United States  

    Taiwan  

View report >

34 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

GlaxoSmithKline P.L.C.

United States

Geron Corp.

United States

Osiris Therapeutics Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.